Roni Mamluk - Jan 3, 2022 Form 4 Insider Report for Ayala Pharmaceuticals, Inc. (AYLA)

Role
President & CEO, Director
Signature
/s/ Roni Mamluk, Ph.D.
Stock symbol
AYLA
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 03:06 PM
Previous filing
Aug 5, 2021
Next filing
May 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AYLA Stock Option Award $0 +128K $0.00 128K Jan 3, 2022 Common Stock 128K $9.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable in sixteen substantially equal quarterly installments following the grant date, such that the option shall be fully vested on January 3, 2026.